Iowa Administrative Code
Agency 641 - Public Health Department
Chapter 154 - Medical Cannabidiol Program
Rule 641-154.33 - Production Requirements
Universal Citation: IA Admin Code 641-154.33
Current through Register Vol. 47, No. 6, September 18, 2024
(1) Cultivation and processing.
a. All phases of production shall take place
in designated, restricted access areas in accordance with rule
641-154.21 (124E).
b. The production process shall be designed
to limit contamination.
c. Each
production area shall allow for access, observation, and inventory of each
plant group.
(2) Crop inputs and plant batches.
a. The manufacturer shall use the secure
sales and inventory tracking system to maintain an electronic record of all
crop inputs. The record shall include the following:
(1) The date of input application;
(2) The name of the employee applying the
crop input;
(3) The crop input that
was applied;
(4) The plants that
received the application; and
(5) A
copy of or electronic link to the safety data sheet for the crop input
applied.
b. At the time
of harvesting, all plants shall be tracked in a batch process with a unique
batch number that shall remain with the batch through final processing into
medical cannabidiol.
c. Each batch
or part of a batch of cannabis plants that contributes to a lot of medical
cannabidiol shall be recorded in the secure sales and inventory tracking system
or other manifest system.
(3) Production of medical cannabidiol.
a. A manufacturer shall
obtain approval from the department for use of any hydrocarbon-based extraction
process.
b. Medical cannabidiol
shall be prepared, handled, and stored in compliance with the sanitation
requirements in this rule.
c. A
manufacturer shall produce shelf-stable, nonperishable forms of medical
cannabidiol.
d. A manufacturer
shall ensure that the cannabinoid content of the medical cannabidiol it
produces is homogenous.
e. Each lot
of medical cannabidiol shall be assigned a unique lot number and recorded in
the secure sales and inventory tracking system or other manifest
system.
(4) General sanitation requirements. A manufacturer shall take all reasonable measures and precautions to ensure that:
a. Any employee who has a communicable
disease does not perform any tasks that might contaminate plant material or
medical cannabidiol;
b.
Hand-washing facilities are:
(1) Convenient
and furnished with running water at a suitable temperature;
(2) Located in all production areas;
and
(3) Equipped with effective
hand-cleaning and -sanitizing preparations and sanitary towel service or
electronic drying devices;
c. All employees working in direct contact
with plant material and medical cannabidiol use hygienic practices while on
duty, including:
(1) Maintaining personal
cleanliness; and
(2) Washing hands
thoroughly in a hand-washing area before starting work and at any other time
when the hands may have become soiled or contaminated;
d. Litter and waste are routinely removed and
the operating systems for waste disposal are routinely inspected;
e. Floors, walls, and ceilings are
constructed with a surface that can be easily cleaned and maintained in good
repair to inhibit microbial growth;
f. Lighting is adequate in all areas where
plant material and medical cannabidiol are processed, stored, or
sold;
g. Screening or other
protection against the entry of pests is provided, including that rubbish is
disposed of to minimize the development of odor and the potential for the waste
becoming an attractant, harborage, or breeding place for pests;
h. Any buildings, fixtures, and other
facilities are maintained in a sanitary condition;
i. Toxic cleaning compounds, sanitizing
agents, and other potentially harmful chemicals are identified and stored in a
separate location away from plant material and medical cannabidiol and in
accordance with applicable local, state, or federal law;
j. All contact surfaces, utensils, and
equipment used in the production of plant material and medical cannabidiol are
maintained in a clean and sanitary condition;
k. The manufacturing facility water supply is
sufficient for necessary operations;
l. Employees have accessible toilet
facilities that are sanitary and in good repair; and
m. Plant material and medical cannabidiol
that could support the rapid growth of undesirable microorganisms are isolated
to prevent the growth of those microorganisms.
(5) Storage.
a. A manufacturer shall store plant material
and medical cannabidiol during production, transport, and testing, ensuring
that:
(1) Plant material and medical
cannabidiol are returned to a secure location immediately after completion;
and
(2) The tanks, vessels, bins,
or bulk containers containing plant material or medical cannabidiol are locked
inside a secure area.
b.
A manufacturer shall store all plant material and medical cannabidiol during
production, transport, and testing, and all saleable medical cannabidiol:
(1) In areas that are maintained in a clean,
orderly, and well-ventilated condition; and
(2) In storage areas that are free from
infestation by insects, rodents, birds, and other pests of any kind.
c. To prevent degradation, at all
times, a manufacturer shall store all plant material and medical cannabidiol
under conditions that will protect the product and its container against
physical, chemical, and microbial contamination and deterioration.
d. A manufacturer shall maintain a separate
secure storage area for medical cannabidiol that is returned from a
dispensary.
(6) Scales. All scales used to weigh usable plant material for purposes of these rules shall be certified in accordance with ISO/IEC 17025 dated 2017, which is incorporated herein by reference.
Disclaimer: These regulations may not be the most recent version. Iowa may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.